Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.43 | N/A |
| PEG Ratio (TTM) | 2.99 | N/A |
| P/S Ratio (TTM) | 3.05 | N/A |
| P/B Ratio (TTM) | 1.24 | N/A |
| P/FCF Ratio (TTM) | 13.34 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.81 | N/A |
| Price to 5YR AVG FCF Ratio | 11.68 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.89% | N/A |
| ROE (TTM) | 8.87% | N/A |
| Net Profit Margin (TTM) | 21.08% | N/A |
| ROIC 5YR AVG | 11.44% | N/A |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 5.06% | 27.66% | 12.40% |
| Revenue | 6.69% | 12.67% | 826.91% |
| Net Income | 4.45% | 25.71% | 10.60% |
| Cash Flow | 437.45% | 16.23% | 7.76% |
Health (42%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.39 | N/A |
| Quick Ratio (TTM) | 0.39 | N/A |
| D/E Ratio (TTM) | 0.14 | N/A |
| Interest Coverage (TTM) | 0.50 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.11 | N/A |
| LTL to 5YR AVG FCF | 5.47 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.78% | N/A |